Back to Trades
Stamoulis Christiana
DirectorCIK 0001502917
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 8
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 3
- Active
- 2025–2026
Across 8 filings between 2025–2026, Stamoulis Christiana, Director, has disclosed $6.0M in transactions — spread across 3 companies. Their disclosed trades are heavily weighted toward selling — $0 in buys and $540.9K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
8 loaded
| Apr 9 | HOLX HOLOGIC INC | Stamoulis Christiana | Director | Disposed | $3.0M |
| Feb 26 | NONE Keenova Therapeutics plc | Stamoulis Christiana | President and CFO | Award | $0 |
| Dec 23 | NONE Keenova Therapeutics plc | Stamoulis Christiana | President and CFO | Tax withheld | $0 |
| Dec 17 | NONE Keenova Therapeutics plc | Stamoulis Christiana | President and CFO | Exercise | $0 |
| Oct 22 | HOLX HOLOGIC INC | Stamoulis Christiana | Director | Sell | $540.9K |
| Sep 25 | NONE Mallinckrodt plc | Stamoulis Christiana | President and CFO | Award | $0 |
| Sep 25 | NONE Mallinckrodt plc | Stamoulis Christiana | President and CFO | Other | $0 |
| Jul 16 | INCY INCYTE CORP | Stamoulis Christiana | EVP & Chief Financial Officer | Grant | $1.9M |
8 filings